RPRX

Royalty Pharma plc

HealthcareBiotechnologyUSUSDPeers →

$54.87

LiveJun 12, 2026

Market cap

$23.6B

52w range

34.08 – 56.50

P / E

—

EPS

—

Volume

3.07M

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Royalty Pharma plc’s valuation

○

Sell-side estimates and price targets skew heavily to US large-caps. We don't have consensus data for this issuer yet.